West Pharmaceutical Services, Inc. Stock
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
04:02:04 2026-09-01 pm EDT
|
5-day change | 1st Jan Change | ||
| 338.65 USD | -0.72% |
|
-2.82% | +23.08% |
| Sep. 01 | Oncology firm Novocure says cyberattack exposed US patient records | RE |
| Aug. 26 | Boston Scientific hit by cyberattack, global operations affected | RE |
| Market Cap | 23.83B 20.56B 19.34B 17.62B 33.13B 2,262B 33.31B 229B 88.98B 1,151B 89.48B 87.54B 3,815B | P/E 2026 * |
39.5x | P/E 2027 * | 34.3x |
|---|---|---|---|---|---|
| Enterprise Value | 23.33B 20.12B 18.93B 17.25B 32.43B 2,214B 32.61B 224B 87.1B 1,126B 87.59B 85.69B 3,735B | EV / Sales 2026 * |
6.91x | EV / Sales 2027 * | 6.35x |
| Free-Float |
92.89% | Yield 2026 * |
0.27% | Yield 2027 * | 0.29% |
Last Transcript : West Pharmaceutical Services, Inc.
| Aug. 26 | West to Participate in Upcoming Investor Conferences | PR |
| Jul. 23 | West Pharmaceutical: Q2 Earnings Snapshot | AQ |
| Jul. 23 | West Reports Second-Quarter 2026 Results | PR |
| Jul. 21 | West Declares Quarterly Dividend | PR |
| Jul. 07 | West to Host Second-Quarter 2026 Conference Call | PR |
| 1 day | -0.72% | ||
| 1 week | -2.82% | ||
| Current month | -0.72% | ||
| 1 month | -0.68% | ||
| 3 months | +7.07% | ||
| 6 months | +33.15% | ||
| Current year | +23.08% |
| 1 week | 335.51 |  | 352.05 |
| 1 month | 335.51 | | 360.28 |
| Current year | 223.83 | | 386 |
| 1 year | 223.83 | | 386 |
| 3 years | 187.43 | | 413.7 |
| 5 years | 187.43 | | 475.35 |
| 10 years | 70.17 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michel Lagarde
CEO | Chief Executive Officer | 52 | 2026-08-30 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
William Feehery
BRD | Director/Board Member | 56 | 2012-02-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/11/26 | Exercice | Chief Financial Officer | 17,408 | 0.0247% | ||
| 6/30/26 | Other | Director | 46 | 0.0001% | ||
| 5/12/26 | Exercice | Executive/Senior Manager | 1,759 | 0.0025% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.72% | -2.82% | +37.13% | -16.93% | 24.01B | |
| -1.30% | -6.20% | -17.89% | +5.91% | 191B | |
| +1.53% | +0.99% | -0.83% | +12.07% | 116B | |
| +2.28% | +0.89% | +13.50% | +89.17% | 61.75B | |
| -0.53% | -1.40% | -3.04% | -32.80% | 51.24B | |
| -0.78% | -1.22% | +27.44% | +50.00% | 51.51B | |
| -1.01% | +1.10% | +19.64% | -11.54% | 34.36B | |
| +0.23% | -1.49% | - | - | 30.73B | |
| -2.02% | -3.05% | -6.45% | +14.80% | 23.23B | |
| -1.29% | -2.87% | -6.29% | -0.53% | 22.68B | |
| Average | -0.37% | -1.96% | +7.02% | +12.24% | 60.65B | |
| Weighted average by Cap. | -0.21% | -2.74% | -0.26% | +14.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.37B 2.91B 2.74B 2.49B 4.69B 320B 4.72B 32.37B 12.6B 163B 12.67B 12.4B 540B | 3.59B 3.09B 2.91B 2.65B 4.99B 340B 5.01B 34.41B 13.39B 173B 13.47B 13.18B 574B |
| Net income | 615M 530M 499M 454M 854M 58.32B 859M 5.9B 2.29B 29.67B 2.31B 2.26B 98.38B | 701M 605M 569M 518M 975M 66.55B 980M 6.73B 2.62B 33.85B 2.63B 2.58B 112B |
| Net Debt | -503M -434M -408M -372M -700M -47.76B -703M -4.83B -1.88B -24.3B -1.89B -1.85B -80.56B | -1.04B -896M -843M -768M -1.44B -98.62B -1.45B -9.97B -3.88B -50.17B -3.9B -3.82B -166B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | $338.65 | -0.72% | 482,801 |
| 26-08-31 | $341.11 | +1.08% | 615,600 |
| 26-08-28 | $337.47 | -2.49% | 496,405 |
| 26-08-27 | $346.09 | -1.09% | 365,990 |
| 26-08-26 | $349.92 | +0.41% | 440,221 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
